Quote | Antares Pharma Inc. (NASDAQ:ATRS)
|Last Trade Date Time:||12/31/1969 07:00:00 pm|
News | Antares Pharma Inc. (NASDAQ:ATRS)
Halozyme Therapeutics announced that they are acquiring Antares Pharma at $5.60 per share in cash, for a total of ~$960M. The deal is expected to close in 1H of 2022. Antares develops products utilizing their drug delivery systems and has multiple royalty streams for their auto-inject...
Form 13F filings show fund managers' top merger arbitrage stocks. Top M&A stocks of the 31 funds I follow. Cerner the top merger arb stock. For further details see: Top Merger Stocks Held By Fund Managers, Mid-Q2 2022
Message Board Posts | Antares Pharma Inc. (NASDAQ:ATRS)
|Ok boys time to cash out. Antares||La Chef||investorshub||05/03/2022 3:24:56 PM|
|whytestocks: $ATRS News Article - Advancements of CAR-T Cell Therapies Importance Grows While Cancer||whytestocks||investorshangout||04/14/2022 12:45:52 PM|
|whytestocks: $ATRS News Article - ANTARES PHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Mer||whytestocks||investorshangout||04/13/2022 6:05:51 PM|
|whytestocks: $ATRS News Article - Antares Pharma Inc shares up 45% on Wednesday: how come?||whytestocks||investorshangout||04/13/2022 5:45:52 PM|
|whytestocks: $ATRS News Article - Lifshitz Law PLLC Announces Investigation of ATRS, HBP, OBNK, ZWS||whytestocks||investorshangout||04/13/2022 2:45:51 PM|
Antares Pharma Inc. Company Name:
ATRS Stock Symbol:
Antares Pharma Inc. Website:
News, Short Squeeze, Breakout and More Instantly...